Your browser doesn't support javascript.
loading
N-Terminomic Changes in Neurons During Excitotoxicity Reveal Proteolytic Events Associated With Synaptic Dysfunctions and Potential Targets for Neuroprotection.
Ameen, S Sadia; Griem-Krey, Nane; Dufour, Antoine; Hossain, M Iqbal; Hoque, Ashfaqul; Sturgeon, Sharelle; Nandurkar, Harshal; Draxler, Dominik F; Medcalf, Robert L; Kamaruddin, Mohd Aizuddin; Lucet, Isabelle S; Leeming, Michael G; Liu, Dazhi; Dhillon, Amardeep; Lim, Jet Phey; Basheer, Faiza; Zhu, Hong-Jian; Bokhari, Laita; Roulston, Carli L; Paradkar, Prasad N; Kleifeld, Oded; Clarkson, Andrew N; Wellendorph, Petrine; Ciccotosto, Giuseppe D; Williamson, Nicholas A; Ang, Ching-Seng; Cheng, Heung-Chin.
Afiliação
  • Ameen SS; Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Victoria, Australia; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.
  • Griem-Krey N; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Dufour A; Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
  • Hossain MI; Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Victoria, Australia; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia; Department of Pharmacology and Toxicology, University of Alabama, Birmingham, Alabama, U
  • Hoque A; St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.
  • Sturgeon S; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.
  • Nandurkar H; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.
  • Draxler DF; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.
  • Medcalf RL; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.
  • Kamaruddin MA; Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Victoria, Australia; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.
  • Lucet IS; Chemical Biology Division, The Walter and Eliza Hall Institute for Medical Research, Parkville, Victoria, Australia; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.
  • Leeming MG; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.
  • Liu D; Department of Neurology, School of Medicine, University of California, Davis, California, USA.
  • Dhillon A; Faculty of Health, Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia.
  • Lim JP; Faculty of Health, Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia.
  • Basheer F; Faculty of Health, Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia.
  • Zhu HJ; Department of Surgery (Royal Melbourne Hospital), University of Melbourne, Parkville, Victoria, Australia.
  • Bokhari L; Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Victoria, Australia; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.
  • Roulston CL; Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.
  • Paradkar PN; CSIRO Health & Biosecurity, Australian Centre for Disease Preparedness, East Geelong, Victoria, Australia.
  • Kleifeld O; Faculty of Biology, Technion-Israel Institute of Technology, Technion City, Haifa, Israel.
  • Clarkson AN; Department of Anatomy, Brain Health Research Centre and Brain Research New Zealand, University of Otago, Dunedin, New Zealand.
  • Wellendorph P; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Ciccotosto GD; Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Victoria, Australia; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia. Electronic address: j.ciccotosto@unimelb.edu.au.
  • Williamson NA; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia. Electronic address: nawill@unimelb.edu.au.
  • Ang CS; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia. Electronic address: ching-seng.ang@unimelb.edu.au.
  • Cheng HC; Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Victoria, Australia; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia. Electronic address: heung@unimelb.edu.au.
Mol Cell Proteomics ; 22(5): 100543, 2023 05.
Article em En | MEDLINE | ID: mdl-37030595
ABSTRACT
Excitotoxicity, a neuronal death process in neurological disorders such as stroke, is initiated by the overstimulation of ionotropic glutamate receptors. Although dysregulation of proteolytic signaling networks is critical for excitotoxicity, the identity of affected proteins and mechanisms by which they induce neuronal cell death remain unclear. To address this, we used quantitative N-terminomics to identify proteins modified by proteolysis in neurons undergoing excitotoxic cell death. We found that most proteolytically processed proteins in excitotoxic neurons are likely substrates of calpains, including key synaptic regulatory proteins such as CRMP2, doublecortin-like kinase I, Src tyrosine kinase and calmodulin-dependent protein kinase IIß (CaMKIIß). Critically, calpain-catalyzed proteolytic processing of these proteins generates stable truncated fragments with altered activities that potentially contribute to neuronal death by perturbing synaptic organization and function. Blocking calpain-mediated proteolysis of one of these proteins, Src, protected against neuronal loss in a rat model of neurotoxicity. Extrapolation of our N-terminomic results led to the discovery that CaMKIIα, an isoform of CaMKIIß, undergoes differential processing in mouse brains under physiological conditions and during ischemic stroke. In summary, by identifying the neuronal proteins undergoing proteolysis during excitotoxicity, our findings offer new insights into excitotoxic neuronal death mechanisms and reveal potential neuroprotective targets for neurological disorders.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sinapses / Morte Celular / Neurônios Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Revista: Mol Cell Proteomics Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sinapses / Morte Celular / Neurônios Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Revista: Mol Cell Proteomics Ano de publicação: 2023 Tipo de documento: Article